Improving prevention strategies for cardiometabolic disease
- 1 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 26 (3), 320-325
- https://doi.org/10.1038/s41591-020-0786-7
Abstract
There is a growing burden of cardiometabolic disease in many parts of the world. Despite some progress in its prevention, more can be done to tackle risks of its development in the community and in different specialty clinics. Currently, the identification and management of those at elevated risk of developing cardiovascular disease or diabetes or with conditions such as fatty liver disease remains fragmented and is not linked to constructive lifestyle advice. In this Perspective, we argue for a more consistent weight-management approach, alongside a holistic assessment of the risk for developing cardiometabolic diseases, offering patients a range of simple or more-intensive evidence-based lifestyle options in an empathetic manner, with encouragement for repeated attempts and a willingness to embrace failure. The authors argue for a consistent weight-management approach, alongside an assessment of the risk for developing cardiometabolic diseases as a prevention strategy.Funding Information
- British Heart Foundation (RE/18/6/34217, RE/18/6/34217)
This publication has 50 references indexed in Scilit:
- The changing face of diabetes complicationsThe Lancet Diabetes & Endocrinology, 2016
- Coverage of a national cardiovascular risk assessment and management programme (NHS Health Check): Retrospective database studyPreventive Medicine, 2015
- Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) studyThe Lancet, 2015
- Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trialBMJ, 2014
- Statins for people at low risk of cardiovascular disease – Authors' replyThe Lancet, 2012
- Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin TherapyPLOS ONE, 2012
- Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trialThe Lancet, 2011
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011
- Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerolDiabetologia, 2011
- Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studiesThe Lancet, 2008